NCT04444349 Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)
| NCT ID | NCT04444349 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing Medical University |
| Condition | Cardiovascular Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-02-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2021-02-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular diseases are the leading causes of death and prescription drug use. Research on certain dietary supplements looks promising as a way to help reduce risk factors. Previous studies showed that CoQ10 levels were decreased in cardiovascular patients and worsening of mitochondrial dysfunction was observed. The overall objective of this study is to determine if supplementing with CoQ10 can reduce inflammatory risk factors in adults with cardiac surgery, independent of other dietary or physical activity changes.
Eligibility Criteria
Inclusion Criteria: * Adult men and women * Who receive cardiovascular surgery * Agree to participate in the surgery and sign the informed consent form Exclusion Criteria: * Pregnant or planning on getting pregnant during the study * Contain a minimum of 2 traits of metabolic syndrome * Refused to participate in the surgery and refused informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04444349 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Cardiovascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04444349 currently recruiting?
Yes, NCT04444349 is actively recruiting participants. Contact the research team at dr.hongliu@foxmail.com for enrollment information.
Where is the NCT04444349 trial being conducted?
This trial is being conducted at Beijing, China, Guangzhou, China, Nanjing, China, Chengdu, China.
Who is sponsoring the NCT04444349 clinical trial?
NCT04444349 is sponsored by Nanjing Medical University. The trial plans to enroll 500 participants.